Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has a diverse ownership structure, with retail investors holding the majority stake at 54%, followed by institutions at 35%. Hedge funds and insiders also have significant ownership. Analyst sentiments and insider ownership indicate potential future trends in the company's performance.